Applied Genetic Technologies Corp. (AGTC) PT Raised to $13 at BMO Capital After Adding XLRP to Valuatoin
Tweet Send to a Friend
BMO Capital analyst Matthew Luchini raised the price target on Applied Genetic Technologies Corp. (NASDAQ: AGTC) to $13.00 (from $7.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
